0001209191-23-054549.txt : 20231106 0001209191-23-054549.hdr.sgml : 20231106 20231106170741 ACCESSION NUMBER: 0001209191-23-054549 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231102 FILED AS OF DATE: 20231106 DATE AS OF CHANGE: 20231106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Amoroso Michael CENTRAL INDEX KEY: 0001830874 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38841 FILM NUMBER: 231380712 MAIL ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PRECISION BIOSCIENCES INC CENTRAL INDEX KEY: 0001357874 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 302 EAST PETTIGREW STREET STREET 2: SUITE A-100 CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 919-314-5512 MAIL ADDRESS: STREET 1: 302 EAST PETTIGREW STREET STREET 2: SUITE A-100 CITY: DURHAM STATE: NC ZIP: 27701 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-11-02 0 0001357874 PRECISION BIOSCIENCES INC DTIL 0001830874 Amoroso Michael C/O PRECISION BIOSCIENCES, INC. 302 E. PETTIGREW STREET, SUITE A-100 DURHAM NC 27701 1 1 0 0 President and CEO 1 Common Stock 2023-11-02 4 M 0 283390 A 352128 D Common Stock 2023-11-03 4 S 0 125025 0.40 D 227103 D Restricted Stock Units 2023-11-02 4 M 0 283390 0.00 D Common Stock 283390 566610 D Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on November 2, 2023. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. The sales were effected pursuant to a Rule 10b5-1 plan adopted on March 24, 2022. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. /s/ Dario Scimeca, Attorney-in-Fact for Michael Amoroso 2023-11-06